Page last updated: 2024-08-22

cladribine and Anemia, Hemolytic, Autoimmune

cladribine has been researched along with Anemia, Hemolytic, Autoimmune in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's6 (50.00)18.2507
2000's4 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffman, PC1
Aslan, DL; Eastlund, T; Long-Tsai, M; Peterson, BA1
Alexanian, R; Daliani, D; Weber, DM1
Croy, D; Fleischman, RA1
Ciepłuch, H; Hałaburda, K; Hellmann, A; Zaucha, JM1
Saven, A1
Błasińska-Morawiec, M; Hellmann, A; Konopka, L; Krykowski, E; Robak, T1
Bussutil, DP; Chasty, RC; Copplestone, JA; Hamon, MD; Myint, H; Orchard, JA; Oscier, DG; Prentice, AG1
Saven, A; Tetreault, SA1
Berentsen, S; Bergheim, J; Hammerstrøm, J; Langholm, R; Shammas, FV; Tjønnfjord, GE; Ulvestad, E1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Wasson, DB1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD1

Reviews

3 review(s) available for cladribine and Anemia, Hemolytic, Autoimmune

ArticleYear
Immune hemolytic anemia--selected topics.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Group Incompatibility; Cladribine; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphocyte Subsets; Lymphoproliferative Disorders; Postoperative Complications; Rituximab; Splenectomy; Transfusion Reaction; Transplantation; Transplantation, Homologous; Venous Thromboembolism; Vidarabine

2009
The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Seminars in hematology, 1996, Volume: 33, Issue:1 Suppl 1

    Topics: Alkylation; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine

1996
Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Advances in experimental medicine and biology, 1989, Volume: 253A

    Topics: 2-Chloroadenosine; Adenosine Deaminase; Anemia, Hemolytic, Autoimmune; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell

1989

Other Studies

9 other study(ies) available for cladribine and Anemia, Hemolytic, Autoimmune

ArticleYear
Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
    Transfusion, 2006, Volume: 46, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Autoantibodies; Cladribine; Erythrocytes; Hemolysis; Humans; Immunoglobulin G; Male; Middle Aged; Waldenstrom Macroglobulinemia

2006
Clinical problem-solving: costly errors.
    The New England journal of medicine, 1995, Oct-19, Volume: 333, Issue:16

    Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Humans; Immunoglobulin M; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse

1995
Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia.
    American journal of hematology, 1995, Volume: 48, Issue:4

    Topics: Anemia, Hemolytic, Autoimmune; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged

1995
2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis.
    Acta haematologica Polonica, 1994, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Remission Induction; Treatment Outcome

1994
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).
    European journal of haematology, 1997, Volume: 58, Issue:2

    Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Cladribine; Coombs Test; Female; Hemolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Retrospective Studies

1997
Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).
    Leukemia & lymphoma, 1998, Volume: 29, Issue:3-4

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cladribine; Female; Humans; Leukemia, B-Cell; Lymphocyte Count; Male; Middle Aged; Red-Cell Aplasia, Pure

1998
Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:1-2

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Cladribine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Waldenstrom Macroglobulinemia

2000
No response to cladribine in five patients with chronic cold agglutinin disease.
    European journal of haematology, 2000, Volume: 65, Issue:1

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Chronic Disease; Cladribine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Treatment Failure

2000
2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.
    Blood, 1988, Volume: 72, Issue:3

    Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Remission Induction; Tumor Cells, Cultured

1988